257 related articles for article (PubMed ID: 18211497)
1. Pyoderma gangrenosum--rebel without a cure?
Jacob SE; Weisman RS; Kerdel FA
Int J Dermatol; 2008 Feb; 47(2):192-4. PubMed ID: 18211497
[TBL] [Abstract][Full Text] [Related]
2. Systemic pyoderma gangrenosum responding to infliximab and adalimumab.
Hubbard VG; Friedmann AC; Goldsmith P
Br J Dermatol; 2005 May; 152(5):1059-61. PubMed ID: 15888172
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Reddick CL; Singh MN; Chalmers RJ
Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
[TBL] [Abstract][Full Text] [Related]
4. [Infliximab for a girl with refractory pyoderma gangrenosum].
Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
[TBL] [Abstract][Full Text] [Related]
5. Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab.
Kleinpenning MM; Langewouters AM; Van De Kerkhof PC; Greebe RJ
J Dermatolog Treat; 2011 Oct; 22(5):261-5. PubMed ID: 20673157
[TBL] [Abstract][Full Text] [Related]
6. [Perineal pyoderma gangrenosum in a girl treated with adalimumab after infliximab failure].
Castro Laria L; Argüelles Arias F; García Martín M; Jiménez Contreras S; Argüelles Martín F; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2011 Aug; 103(8):439-41. PubMed ID: 21867361
[No Abstract] [Full Text] [Related]
7. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.
Duchini G; Itin P; Arnold A
Adv Skin Wound Care; 2011 May; 24(5):217-20. PubMed ID: 21505282
[TBL] [Abstract][Full Text] [Related]
8. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
9. Recalcitrant pyoderma gangrenosum treated with thalidomide.
Federman GL; Federman DG
Mayo Clin Proc; 2000 Aug; 75(8):842-4. PubMed ID: 10943240
[TBL] [Abstract][Full Text] [Related]
10. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.
Brooklyn TN; Dunnill MG; Shetty A; Bowden JJ; Williams JD; Griffiths CE; Forbes A; Greenwood R; Probert CS
Gut; 2006 Apr; 55(4):505-9. PubMed ID: 16188920
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil as therapy for pyoderma gangrenosum.
Eaton PA; Callen JP
Arch Dermatol; 2009 Jul; 145(7):781-5. PubMed ID: 19620559
[TBL] [Abstract][Full Text] [Related]
13. Infliximab for peristomal pyoderma gangrenosum.
Mimouni D; Anhalt GJ; Kouba DJ; Nousari HC
Br J Dermatol; 2003 Apr; 148(4):813-6. PubMed ID: 12752145
[TBL] [Abstract][Full Text] [Related]
14. The role of anti-tumor necrosis factor-alpha therapy in Pyoderma gangrenosum associated with inflammatory bowel disease.
Reguiaï Z; Grange F
Am J Clin Dermatol; 2007; 8(2):67-77. PubMed ID: 17428111
[TBL] [Abstract][Full Text] [Related]
15. Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy.
Agarwal A; Andrews JM
Aliment Pharmacol Ther; 2013 Sep; 38(6):563-72. PubMed ID: 23914999
[TBL] [Abstract][Full Text] [Related]
16. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
[TBL] [Abstract][Full Text] [Related]
17. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
Stichweh DS; Punaro M; Pascual V
Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum.
Conrad C; Trüeb RM
J Dtsch Dermatol Ges; 2005 May; 3(5):334-42. PubMed ID: 16372799
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab.
Grange F; Djilali-Bouzina F; Weiss AM; Polette A; Guillaume JC
Dermatology; 2002; 205(3):278-80. PubMed ID: 12399677
[TBL] [Abstract][Full Text] [Related]
20. [Pyoderma gangrenosum is 100 years old. From Louis Brocq to biotherapies].
Farhi D; Wallach D; Avril MF
Rev Prat; 2008 Feb; 58(4):457-61. PubMed ID: 18506988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
